Compare TIRX & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TIRX | COSM |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Other Pharmaceuticals |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5M | 15.4M |
| IPO Year | 2021 | 2013 |
| Metric | TIRX | COSM |
|---|---|---|
| Price | $0.47 | $0.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 200.6K | ★ 697.2K |
| Earning Date | 08-22-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 158.74 | 6.69 |
| 52 Week Low | $0.42 | $0.28 |
| 52 Week High | $6.45 | $1.32 |
| Indicator | TIRX | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 26.91 | 36.91 |
| Support Level | $0.47 | $0.41 |
| Resistance Level | $1.10 | $0.59 |
| Average True Range (ATR) | 0.13 | 0.05 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 5.70 | 41.30 |
Tian Ruixiang Holdings Ltd is an Insurance Brokerage firm. It distributes a wide range of insurance products, which are categorized into two groups; property and casualty insurance, such as commercial property insurance, liability insurance, accidental insurance, and automobile insurance; and other insurances, such as health insurance, life insurance, and miscellaneous insurances. It also generates a small amount of revenue from risk management services. The firm act on behalf of its customers seeking insurance coverage from insurance companies. It generates revenue from the provision of insurance brokerage services.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.